Cosette Pharmaceuticals acquires Mayne Pharma Group for $430 million
NEW YORK: Cosette Pharmaceuticals, Inc., a U.S.-based pharmaceutical company, announced Thursday that it has entered into a definitive agreement to acquire all outstanding shares of Mayne Pharma Group Limited (ASX: MYX) for AUD $7.40 per share. The total consideration for…